Concerns With Statistical Analysis of 2016 CDC Opioid Guideline and Sickle Cell Outcomes-Reply
JAMA Intern Med
.
2024 Sep 1;184(9):1134.
doi: 10.1001/jamainternmed.2024.3022.
Authors
Hyeun Ah Kang
1
,
Yahan Zhang
1
,
Kenneth I Ataga
2
Affiliations
1
Division of Health Outcomes, College of Pharmacy, The University of Texas at Austin.
2
Center for Sickle Cell Disease, Department of Medicine, The University of Tennessee Health Science Center at Memphis.
PMID:
39037806
DOI:
10.1001/jamainternmed.2024.3022
No abstract available
MeSH terms
Analgesics, Opioid* / therapeutic use
Anemia, Sickle Cell*
Centers for Disease Control and Prevention, U.S.*
Humans
Practice Guidelines as Topic*
United States / epidemiology
Substances
Analgesics, Opioid